Invasive fungal diseases during COVID-19: We should be prepared.
作者信息
Gangneux J-P, Bougnoux M-E, Dannaoui E, Cornet M, Zahar J R
机构信息
Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de recherche en santé environnement et Travail) - UMR_S 1085, CHU Rennes, 2, rue Henri Le Guilloux, 35033 Rennes, France.
Service de microbiologie clinique, unité de parasitologie-mycologie, hôpital Necker-Enfants-Malades, AP-HP, Centre - université de Paris, France; Unité biologie et pathogénicité fongiques - Institut Pasteur, Paris, France.
出版信息
J Mycol Med. 2020 Jun;30(2):100971. doi: 10.1016/j.mycmed.2020.100971. Epub 2020 Apr 6.
Abstract
摘要
相似文献
1
Invasive fungal diseases during COVID-19: We should be prepared.2019冠状病毒病期间的侵袭性真菌病：我们应做好准备。
J Mycol Med. 2020 Jun;30(2):100971. doi: 10.1016/j.mycmed.2020.100971. Epub 2020 Apr 6.
2
Opportunistic Fungal Infections in the Epidemic Area of COVID-19: A Clinical and Diagnostic Perspective from Iran.COVID-19 流行地区的机会性真菌感染：来自伊朗的临床和诊断视角。
Mycopathologia. 2020 Aug;185(4):607-611. doi: 10.1007/s11046-020-00472-7. Epub 2020 Jul 31.
3
Systemic mycoses: a potential alert for complications in COVID-19 patients.系统性真菌病：COVID-19 患者并发症的潜在警示。
Future Microbiol. 2020 Sep;15:1405-1413. doi: 10.2217/fmb-2020-0156.
4
Bacterial and fungal infections among patients with SARS-CoV-2 pneumonia.新型冠状病毒肺炎患者中的细菌和真菌感染。
Infez Med. 2020 Jun 1;28(suppl 1):29-36.
5
Patients with arterial hypertension and COVID-19 are at higher risk of ICU admission.患有动脉高血压和新冠肺炎的患者入住重症监护病房的风险更高。
Br J Anaesth. 2020 Aug;125(2):e254-e255. doi: 10.1016/j.bja.2020.04.056. Epub 2020 Apr 27.
6
Risk of COVID-19 disease in the elderly population and physiotherapy.老年人群中感染新型冠状病毒肺炎的风险与物理治疗
Physiotherapy. 2020 Sep;108:76-77. doi: 10.1016/j.physio.2020.05.003. Epub 2020 Jun 2.
7
Fighting the COVID-19 pandemic: An ophthalmologist's experience in an intensive care unit at the All India Institute of Medical Sciences.抗击新冠疫情：一位眼科医生在全印度医学科学研究所重症监护病房的经历
Indian J Ophthalmol. 2020 Jul;68(7):1482. doi: 10.4103/ijo.IJO_1226_20.
8
Pulmonary embolism in patients with COVID-19 pneumonia.COVID-19 肺炎患者中的肺栓塞。
Eur Respir J. 2020 Jul 30;56(1). doi: 10.1183/13993003.01365-2020. Print 2020 Jul.
9
Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.免疫功能正常患者的侵袭性曲霉病和冠状病毒病致死。
Emerg Infect Dis. 2020 Jul;26(7):1636-1637. doi: 10.3201/eid2607.201603. Epub 2020 Jun 21.
10
Subacute Aspergillosis "Fungal Balls" Complicating COVID-19.亚急性曲霉病“真菌球”并发新型冠状病毒肺炎
J Investig Med High Impact Case Rep. 2020 Jan-Dec;8:2324709620966475. doi: 10.1177/2324709620966475.
引用本文的文献
1
Oral Candidiasis in COVID-19 Patients Under Critical Care Involving Non-albicans Candida Species Alongside Candida albicans.危重症新型冠状病毒肺炎患者的口腔念珠菌病：白色念珠菌与非白色念珠菌并存
Cureus. 2025 Jul 14;17(7):e87949. doi: 10.7759/cureus.87949. eCollection 2025 Jul.
2
Correlation between the severity of COVID-19 infection and the presence of oropharyngeal candidiasis: a cross-sectional study in Al-Diwaniyah Hospital, Iraq.2019冠状病毒病感染严重程度与口咽念珠菌病之间的相关性：伊拉克迪瓦尼亚医院的一项横断面研究
Pan Afr Med J. 2025 Jan 13;50:25. doi: 10.11604/pamj.2025.50.25.43995. eCollection 2025.
3
The Other Side of the Coin of Pulmonary Fungal Diseases: Toward New Paradigms.肺部真菌病的另一面：迈向新范式
Am J Respir Crit Care Med. 2025 Jun;211(6):901-903. doi: 10.1164/rccm.202504-0803ED.
4
Non-Neoformans Cryptococcal Infections in the Post-Coronavirus Disease-19 (COVID-19) Era: Are We Ready to Face the Emerging Challenge?新型冠状病毒肺炎（COVID-19）疫情后时代的非新生隐球菌性隐球菌感染：我们是否准备好应对这一新兴挑战？
Asian J Neurosurg. 2024 Nov 4;20(1):190-195. doi: 10.1055/s-0044-1791998. eCollection 2025 Mar.
5
Endoscopic Orbital Clearance/Debridement: A Potential Substitute for Orbital Exenteration in Rhino-orbital Mucormycosis.内镜下眼眶清理/清创术：鼻眶毛霉菌病中眼眶内容剜除术的潜在替代方法
Int Arch Otorhinolaryngol. 2025 Jan 23;29(1):1-7. doi: 10.1055/s-0044-1791645. eCollection 2025 Jan.
6
Rhinocerebral Mucormycosis in Patients with Kidney Disease Following Covid 19 Infection.新型冠状病毒肺炎感染后肾病患者的鼻脑毛霉病
Indian J Nephrol. 2024 Jul-Aug;34(4):369-373. doi: 10.25259/ijn_233_21. Epub 2024 Jul 20.
7
Structures of trehalose-6-phosphate synthase, Tps1, from the fungal pathogen : A target for antifungals.真菌病原体海藻糖-6-磷酸合酶（Tps1）的结构：抗真菌药物的作用靶点。
Proc Natl Acad Sci U S A. 2024 Aug 6;121(32):e2314087121. doi: 10.1073/pnas.2314087121. Epub 2024 Jul 31.
8
Screening of Candida spp. in wastewater in Brazil during COVID-19 pandemic: workflow for monitoring fungal pathogens.巴西在 COVID-19 大流行期间对废水中念珠菌属的筛查：监测真菌病原体的工作流程。
BMC Biotechnol. 2024 Jun 22;24(1):43. doi: 10.1186/s12896-024-00868-z.
9
Risk factors and clinical presentation of rhino-orbital mucormycosis: Lesson learnt during Covid pandemic.鼻眶毛霉菌病的危险因素及临床表现：新冠疫情期间的经验教训
J Family Med Prim Care. 2024 Apr;13(4):1354-1361. doi: 10.4103/jfmpc.jfmpc_1259_23. Epub 2024 Apr 22.
10
Severe mold fungal infections in critically ill patients with COVID-19.COVID-19 重症患者的严重霉菌真菌感染。
Future Microbiol. 2024 Jun 12;19(9):825-840. doi: 10.2217/fmb-2023-0261. Epub 2024 May 31.
本文引用的文献
1
Clinical and virological data of the first cases of COVID-19 in Europe: a case series.欧洲首批 COVID-19 病例的临床和病毒学数据：一项病例系列研究。
Lancet Infect Dis. 2020 Jun;20(6):697-706. doi: 10.1016/S1473-3099(20)30200-0. Epub 2020 Mar 27.
2
Clinical and immunological features of severe and moderate coronavirus disease 2019.新型冠状病毒病 2019 重症和中度患者的临床和免疫学特征。
J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.
3
Coronavirus disease 2019: What we know?新型冠状病毒肺炎：我们知道什么？
J Med Virol. 2020 Jul;92(7):719-725. doi: 10.1002/jmv.25766. Epub 2020 Mar 28.
4
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study.中国武汉严重 COVID-19 患者的临床病程和结局：一项单中心、回顾性、观察性研究。
Lancet Respir Med. 2020 May;8(5):475-481. doi: 10.1016/S2213-2600(20)30079-5. Epub 2020 Feb 24.
5
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.中国武汉 99 例 2019 年新型冠状病毒肺炎患者的流行病学和临床特征：描述性研究。
Lancet. 2020 Feb 15;395(10223):507-513. doi: 10.1016/S0140-6736(20)30211-7. Epub 2020 Jan 30.
6
Influenza Coinfection: Be(a)ware of Invasive Aspergillosis.流感合并感染：谨防侵袭性曲霉病。
Clin Infect Dis. 2020 Jan 2;70(2):349-350. doi: 10.1093/cid/ciz391.
7
Invasive aspergillosis in patients admitted to the intensive care unit with severe influenza: a retrospective cohort study.重症监护病房中因严重流感入院的患者侵袭性曲霉菌病：一项回顾性队列研究。
Lancet Respir Med. 2018 Oct;6(10):782-792. doi: 10.1016/S2213-2600(18)30274-1. Epub 2018 Jul 31.
8
Influenza-Associated Aspergillosis in Critically Ill Patients.重症患者中的流感相关性曲霉病
Am J Respir Crit Care Med. 2017 Aug 15;196(4):524-527. doi: 10.1164/rccm.201612-2540LE. Epub 2017 Apr 7.
9
An estimation of burden of serious fungal infections in France.法国严重真菌感染负担的评估。
J Mycol Med. 2016 Dec;26(4):385-390. doi: 10.1016/j.mycmed.2016.11.001. Epub 2016 Nov 22.
10
Population-based analysis of invasive fungal infections, France, 2001-2010.2001年至2010年法国侵袭性真菌感染的基于人群的分析。
Emerg Infect Dis. 2014 Jul;20(7):1149-55. doi: 10.3201/eid2007.140087.
Zotero 插件